ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy disease medicine innovation art

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Supplement: Art Caplan
Karen Pallarito | Jan 1, 2008 | 4 min read
Art Caplan By Karen Pallarito A conversation with Penn's renowned ethicist. RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Turning Tobacco into Therapies Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Technology Roundup DUSTIN FENSTERMACHER / WONDERFUL MACHINE As a Columbia University philosophy student in the 1970s, Arthur Caplan listened to ongoing discussions about the ethics of
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
Capsule Reviews
Bob Grant | Nov 1, 2013 | 4 min read
Tracks and Shadows, The Gap, The Cure in the Code, and An Appetite for Wonder
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Epilepsy Innovations Mount, but Key Mysteries Remain
Steve Bunk | Jan 17, 1999 | 9 min read
If many epilepsy sufferers remain refractory to current therapies, it isn't for a lack of research and development effort. Presentations at the recent annual meeting of the professional American Epilepsy Society (AES) in San Diego described a spate of novel medications, advances in imaging technology, new surgery techniques, and the promising early results of a clinical trial using xenotransplantation. But the question remains: Will research finally dispel the stubborn mysteries of epilepsy tha
Illustration showing a puzzle piece of DNA being removed
Large Scientific Collaborations Aim to Complete Human Genome
Brianna Chrisman and Jordan Eizenga | Sep 1, 2022 | 10+ min read
Thirty years out from the start of the Human Genome Project, researchers have finally finished sequencing the full 3 billion bases of a person’s genetic code. But even a complete reference genome has its shortcomings.
Newly Elected Members Bring Diversity, Change To Institute Of Medicine
Edward Silverman | Nov 26, 1995 | 4 min read
Institute Of Medicine Author: Edward R. Silverman Sidebar: Members of the IOM With the election last month of its latest slate of members, the Institute of Medicine (IoM)-an honor society affiliated with the National Academy of Sciences-will have more women in its ranks than at any other time in its 25-year history when the honorees are inducted next year. Including the 15 women who are among the crop of 55 new members elected in October, women now constitute 21 percent of the society's 519 r
Mapping the Terrain
Thana Poopat and Nantiya Tangwisutijit | Jan 12, 2010 | 10+ min read
color = "#B693B5"; Mapping the Terrain Thailand’s first National Biotechnology Policy Framework served as a roadmap for significant progress, but it had a rocky start. A look back at the Framework provides signposts to guide the way forward. By Thana Poopat and Nantiya Tangwisutijit During the past 3 decades, Thailand has increasingly prioritized biotechnology investment. From medicine to food to plastics to energy, Thailand has emerg

Run a Search

ADVERTISEMENT